Got $2500? Check Out These 3 Alzheimer’s Therapy Stocks,

ANVS401 is currently in phase 2a of clinical trials, and on June 1 the company reported that the drug appeared to help patients with Alzheimer’s score …, ANVS401 is currently in phase 2a of clinical trials, and on June 1 the company reported that the drug appeared to help patients with Alzheimer’s score …, Read More

Scroll to Top